(Reuters Health) – Men who are treated for prostate cancer with hormone-targeted therapy have a higher risk of developing kidney problems, a new study suggests. The treatment, known as androgen deprivation therapy, lowers the risk of death among men with advanced, aggressive prostate cancer. However, researchers said it’s increasingly being used to treat possible recurrences […]